The table below shows Royalty Pharma plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$630.58M
$609.29M
$578.66M
$568.25M
$564.69M
$537.27M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$39.79M
$50.50M
$300.50M
$50.50M
$500.00K
$500.00K
RPRX annual revenue (10-K history)
Royalty Pharma plc reported annual revenue of $2.38B for fiscal year 2025. That is up 5.1% from $2.26B in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $1.79B (FY 2018) to $2.38B. Figures come from the company's audited annual reports as filed with the SEC.